Back
Ares Management 10K Form
Buy
74
ARES
Ares Management
Last Price:
171.42
Seasonality Move:
8.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-06 | 10Q | ARES/Ares Management Quarterly |
2023-08-03 | 10Q | ARES/Ares Management Quarterly |
2023-05-08 | 10Q | ARES/Ares Management Quarterly |
2022-11-07 | 10Q | ARES/Ares Management Quarterly |
2022-08-05 | 10Q | ARES/Ares Management Quarterly |
2022-05-09 | 10Q | ARES/Ares Management Quarterly |
Receive ARES News And Ratings
See the #1 stock for the next 7 days that we like better than ARES
ARES Financial Statistics
Sales & Book Value
Annual Sales: | $4.99B |
---|---|
Cash Flow: | $402.93M |
Price / Cash Flow: | 0 |
Annual Sales: | $10.05 |
Price / Book: | 16.58 |
Profitability
EPS (TTM): | 2.17000 |
---|---|
Net Income (TTM): | $460.38M |
Gross Margin: | $3.5B |
Return on Equity: | 9.11% |
Return on Assets: | 1.9% |
Ares Management Earnings Forecast
Key Ares Management Financial Ratios
- The Gross Profit Margin over the past 13 years for ARES is 70.19%.
- The Selling, General & Administrative Expenses for ARES have been equal to 25.42% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 181.49% of Operating Income.
- The Net Earning history of ARES is 9.51% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 5 years.
Ares Management Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | ARES |
CUSIP: | 03990B |
Website: | aresmgmt.com |
Debt
Debt-to-Equity Ratio: | 7.09 |
---|---|
Current Ratio: | 0.67 |
Quick Ratio: | 0.67 |
Price-to-Earnings
Trailing P/E Ratio: | 67.95 |
---|---|
Forward P/E Ratio: | 29.64 |
ARES Technical Analysis vs Fundamental Analysis
Buy
74
Ares Management (ARES)
is a Buy
Is Ares Management a Buy or a Sell?
-
Ares Management stock is rated a Buy
The current Ares Management [ARES] share price is $164.44. The Score for ARES is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.